wildtyp
human
parainfluenza
viru
type
wt
one
gene
pv
gene
encod
polymeraseassoci
phosphoprotein
p
accessori
v
protein
gener
viru
ko
pv
gene
encod
p
protein
examin
role
v
replic
vivo
potenti
live
attenu
viru
vaccin
prevent
express
v
protein
sever
impair
viru
recoveri
cdna
growth
vitro
particularli
ifncompet
cell
ko
unlik
wt
strongli
induc
permit
ifn
signal
lead
establish
robust
antivir
state
ko
infect
induc
extens
syncytia
cytopath
due
apoptosi
necrosi
replic
ko
highli
restrict
respiratori
tract
african
green
monkey
differenti
primari
human
airway
epitheli
hae
cultur
suggest
v
protein
essenti
effici
replic
organ
epitheli
cell
ko
overattenu
use
live
attenu
vaccin
publish
elsevi
inc
human
parainfluenza
viru
serotyp
negativestrand
nonseg
envelop
rna
virus
belong
paramyxovirida
famili
hpiv
major
caus
respiratori
ill
children
account
pediatr
hospit
acut
respiratori
tract
infect
murphi
hpiv
diseas
rang
mild
upper
respiratori
tract
ill
urti
sever
lower
respiratori
tract
diseas
includ
croup
bronchiol
pneumonia
thought
import
caus
urti
croup
undifferenti
febril
ill
kapikian
et
al
parrott
et
al
current
effect
antivir
therapi
vaccin
treat
prevent
hpiv
infect
unlik
member
genu
respiroviru
rubulaviru
encod
polypeptid
gene
arrang
order
genom
nucleotid
length
requir
genom
nucleotid
length
multipl
six
effici
replic
known
rule
six
skiadopoulo
et
al
transcript
replic
direct
viral
nucleocapsid
protein
n
phosphoprotein
p
larg
polymeras
l
protein
karron
collin
fusion
f
hemagglutininneuraminidas
hn
glycoprotein
major
protect
antigen
hpiv
associ
viral
envelop
along
intern
matrix
protein
murphi
remain
polypeptid
accessori
v
protein
identifi
antagonist
type
interferon
ifn
respons
andrejeva
et
al
et
al
horvath
pool
et
al
young
et
al
pv
gene
encod
phosphoprotein
p
subunit
viral
polymeras
accessori
v
protein
ohgimoto
et
al
unedit
transcript
pv
gene
yield
mrna
code
v
protein
altern
cotranscript
insert
two
nontempl
guanin
nucleotid
rna
edit
gener
mrna
frame
shift
code
p
protein
therefor
p
v
protein
share
first
ntermin
amino
acid
distinct
ctermini
rna
edit
insert
pseudotempl
g
nucleotid
conserv
viral
mechan
occur
nearli
member
five
genera
subfamili
paramyxovirina
karron
collin
p
protein
essenti
compon
viral
rna
polymeras
multipl
role
mrna
transcript
genom
replic
lamb
park
primari
function
v
protein
appear
inhibit
innat
antivir
respons
though
v
also
believ
play
part
prevent
apoptosi
virolog
regul
viral
rna
synthesi
didcock
et
al
et
al
lin
lamb
pool
et
al
wansley
park
latter
function
may
mediat
bind
v
protein
viru
n
l
protein
well
rna
lin
et
al
nishio
et
al
nishio
et
al
randal
bermingham
addit
function
v
protein
rubulavirus
compon
virion
wherea
v
detect
virion
respirovirus
morbillivirus
curran
et
al
paterson
et
al
role
v
virion
morphogenesi
suggest
remain
defin
detail
innat
immun
respons
power
host
defens
viru
infect
result
target
interfer
protein
encod
mani
divers
virus
fensterl
sen
goodbourn
et
al
rna
viru
infect
detect
number
host
cell
pathogen
recognit
receptor
prr
induc
innat
immun
respons
ifn
apoptot
respons
tolllik
receptor
express
cell
surfac
endosom
recogn
specif
viral
product
viral
nucleic
acid
present
intracellular
vesicl
extracellular
environ
wherea
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
gene
constitut
express
rna
helicas
detect
viral
rna
cytosol
activ
either
type
prr
signal
synthesi
subsequ
signal
receptor
koyama
et
al
yoneyama
fujita
yoneyama
et
al
ifn
secret
cell
act
either
autocrin
paracrin
manner
effect
ifn
host
cell
initi
engag
multimer
ifnar
ifnarassoci
tyrosin
kinas
phosphoryl
receptor
subunit
therebi
trigger
recruit
phosphoryl
releas
receptor
cytoplasm
activ
associ
form
complex
known
interferonstimul
gene
factor
transloc
nucleu
activ
transcript
ifninduc
gene
isg
isg
establish
antivir
state
infect
uninfect
cell
also
serv
augment
adapt
immun
respons
fensterl
sen
one
attract
strategi
propos
attenu
virus
use
live
viru
vaccin
involv
delet
mutat
ifn
antagonist
encod
virus
talon
et
al
multifunct
v
protein
shown
counteract
ifn
respons
two
step
limit
induct
ifn
biosynthesi
viral
dsrna
interact
rna
helicas
andrejeva
et
al
child
et
al
block
ifn
signal
engag
protein
cytoplasm
complex
cellular
ubiquitin
ligas
result
ubiquitin
proteasom
degrad
andrejeva
et
al
nishio
et
al
nishio
et
al
data
suggest
mutat
ablat
v
protein
could
use
strategi
gener
live
attenu
vaccin
candid
howev
potenti
complic
abrog
ifnindepend
function
v
polymeras
activ
replic
mutat
could
result
reduct
yield
live
vaccin
cell
cultur
manufactur
overattenu
vaccin
vivo
previous
two
recombin
virus
one
mutat
prevent
v
protein
express
entir
one
mutat
creat
v
protein
truncat
ctermin
domain
deriv
toshiba
strain
nishio
et
al
mutant
highli
restrict
replic
number
cell
line
includ
vero
cell
produc
type
ifn
nishio
et
al
howev
effici
growth
two
v
mutant
vivo
report
full
genom
sequenc
present
present
studi
use
ruleofsixcompli
recoveri
system
gener
independ
recombin
ko
v
express
ablat
introduct
alter
rna
edit
site
pv
gene
similar
mutant
gener
nishio
et
al
sequenc
analysi
recov
ko
viru
confirm
wildtyp
sequenc
express
protein
skiadopoulo
et
al
ko
contain
one
incident
mutat
noncod
region
judg
biolog
insignific
studi
extend
previou
observ
examin
abil
ko
induc
synthesi
ifn
inhibit
ifn
signal
receptor
replic
vivo
nonhuman
primat
replic
human
welldifferenti
primari
airway
epitheli
cell
cultur
ko
found
restrict
growth
vitro
due
enhanc
cytopath
effect
cpe
inabl
antagon
induct
ifn
ifn
signal
receptor
defect
prove
highli
restrict
growth
african
green
monkey
agm
cultur
human
ciliat
airway
epithelium
hae
wildtyp
wt
p
v
mrna
encod
overlap
read
frame
illustr
fig
paramyxovirus
use
uniqu
mechan
mrna
edit
insert
pseudotempl
g
residu
transcript
p
gene
upon
read
specif
edit
site
depict
fig
viral
polymeras
occasion
stutter
slippag
nascent
mrna
occur
one
extra
g
nucleotid
ad
p
gene
genu
respiro
avula
henipaand
morbilliviru
unedit
mrna
encod
p
insert
one
g
residu
produc
v
mrna
opposit
occur
rubulavirus
unedit
mrna
encod
v
edit
version
encod
p
via
twonucleotid
frame
shift
fig
group
previous
demonstr
possibl
prevent
v
protein
express
mutat
rna
edit
site
pv
gene
nishio
et
al
use
revers
genet
system
base
sequenc
low
passag
clinic
isol
replic
high
titer
nonhuman
primat
nolan
et
al
alter
pv
edit
site
creat
twonucleotid
frame
shift
unedit
mrna
encod
p
disrupt
string
g
nucleotid
substitut
mutagenesi
order
inactiv
edit
fig
done
without
introduc
code
mutat
p
observ
recombin
viru
ko
lower
frequenc
recoveri
cdna
ifncompet
cell
ko
recov
transfect
recoveri
rate
wherea
recov
transfect
recoveri
one
five
recov
ko
popul
edit
site
restor
exactli
wt
viru
though
introduc
sequenc
chang
eg
restrict
site
present
sequenc
recov
viru
tabl
mutant
anoth
mutant
tabl
mutant
edit
site
restor
wt
viru
except
three
g
residu
longer
thu
p
edit
site
gain
singl
nucleotid
length
compar
origin
v
ko
mutant
sequenc
gain
appear
compens
singlenucleotid
delet
poli
tract
end
n
geneend
signal
tabl
mutant
third
mutant
ten
c
mutat
open
read
frame
n
p
highli
impair
growth
vitro
tabl
mutant
final
two
recov
ko
isol
p
edit
site
retain
mutat
origin
v
ko
mutant
although
contain
singl
differ
nucleotid
substitut
geneend
signal
n
gene
tabl
mutant
mutant
contain
substitut
nucleotid
nt
n
geneend
signal
whose
phenotyp
consequ
investig
n
geneend
region
site
adventiti
mutat
recov
ko
isol
therefor
includ
tabl
mutant
contain
g
substitut
nucleotid
chang
length
poli
tract
geneend
signal
residu
mutat
natur
variat
affect
length
poli
sequenc
geneend
signal
common
paramyxovirus
gener
usual
without
phenotyp
consequ
collin
crow
kolakofski
et
al
rassa
et
al
therefor
mutant
analyz
western
blot
analysi
reveal
express
gene
downstream
geneend
mutat
encod
p
protein
least
equival
express
p
cell
fig
h
postinfect
hpi
n
p
protein
express
effici
ko
fig
indic
mutat
geneend
sequenc
ko
function
impair
mrna
synthesi
consid
incident
mutat
littl
biolog
signific
ko
replic
effici
vitro
sequenc
analysi
entir
genom
show
free
addit
adventiti
mutat
western
blot
analysi
infect
cell
lysat
use
antibodi
direct
nand
ctermini
v
protein
confirm
ko
express
v
protein
fig
addit
smaller
band
detect
either
ko
antibodi
specif
nterminu
pv
v
p
readili
detect
indic
neither
viru
express
w
protein
alter
edit
site
prevent
express
ctermin
truncat
v
w
protein
therefor
isol
use
throughout
remaind
studi
ko
nucleotid
sequenc
pv
mrna
edit
site
shown
p
v
mrna
underlin
nucleotid
denot
site
seven
v
mrna
nine
p
mrna
g
residu
indic
p
v
protein
share
ident
ntermin
sequenc
uniqu
ctermin
sequenc
edit
site
b
diagram
cdna
use
recov
infecti
ko
uniqu
silent
restrict
enzym
site
asci
bsteii
agei
sacii
introduc
order
alter
edit
site
p
gene
nucleotid
sequenc
mrna
edit
site
p
orf
shown
three
nucleotid
substitut
introduc
disabl
edit
site
present
bold
c
express
protein
cell
mockinfect
infect
ko
cell
infect
moi
tcid
cell
lyse
h
postinfect
hpi
protein
express
analyz
sdspage
immunoblot
antibodi
n
p
v
protein
cellular
gapdh
serv
load
control
sequenc
analysi
recov
ko
antigenom
sens
nucleotid
sequenc
select
region
genom
b
adventiti
mutat
frequent
note
n
geneend
sequenc
recov
ko
mutant
geneend
sequenc
box
c
sequenc
p
edit
site
recov
virus
compar
ko
cdna
sequenc
use
viru
recoveri
p
edit
site
mutat
creat
ko
indic
bold
type
e
sequenc
virus
recov
ko
cdna
five
transfect
underlin
nucleotid
indic
adventiti
mutat
f
recov
ko
clone
shade
indic
viru
use
experi
studi
singl
multicycl
replic
ko
assess
vero
cell
infect
moi
tcid
cell
respect
fig
b
cell
human
type
ii
pneumocyt
cell
line
ko
replic
poorli
reach
peak
titer
log
tcid
ml
follow
high
moi
inocul
lower
peak
titer
peak
titer
log
tcid
ml
similarli
ko
reach
peak
titer
log
tcid
ml
follow
low
moi
inocul
lower
peak
titer
peak
titer
log
tcid
ml
furthermor
titer
ko
reach
plateau
day
postinfect
pi
titer
increas
day
pi
replic
ko
also
evalu
two
monkey
cell
line
fig
b
african
green
monkey
vero
cell
select
unabl
produc
type
interferon
ifn
would
substrat
use
manufactur
live
attenu
vaccin
ifncompet
rhesu
monkey
kidney
cell
chosen
replic
effici
cell
line
ko
replic
slightli
restrict
aliquot
cultur
media
replac
interv
titrat
serial
dilut
cell
score
hemadsorpt
mean
viru
titer
time
point
express
log
tcid
ml
se
c
plaqu
size
comparison
ko
monolay
vero
cell
left
panel
cell
right
panel
infect
indic
virus
moi
tcid
cell
cell
overlaid
methylcellulos
incub
day
pi
fix
methanol
plaqu
stain
polyclon
rabbit
immun
serum
develop
horseradish
peroxidaseconjug
antirabbit
antibodi
peroxidas
substrat
plaqu
imag
without
magnif
follow
high
moi
inocul
significantli
restrict
vero
cell
compar
follow
low
moi
inocul
p
b
twoway
anova
bonferroni
posttest
multicycl
growth
curv
replic
ko
restrict
vero
cell
peak
titer
log
tcid
ml
cell
peak
titer
log
tcid
ml
compar
peak
titer
log
tcid
ml
vero
cell
log
tcid
ml
cell
sequenc
analysi
ko
isol
cell
cultur
complet
growth
curv
confirm
mutat
introduc
pv
edit
site
remain
intact
data
indic
growth
ko
significantli
restrict
vitro
although
lesser
extent
absenc
cellular
ifn
respons
sensit
replic
ko
elev
temperatur
also
evalu
vitro
determin
whether
v
delet
alter
stabil
replic
complex
replic
compar
restrict
n
data
shown
indic
temperatur
sensit
replic
order
assess
celltocel
spread
ko
infect
monolay
vero
cell
serial
dilut
viru
use
methylcellulos
overlay
fig
follow
incub
day
plaqu
visual
immunostain
antibodi
plaqu
size
compar
ko
vero
cell
ko
plaqu
approxim
smaller
plaqu
pixel
ko
versu
p
b
cell
dramat
reduct
plaqu
size
ko
observ
compar
versu
p
b
thu
ko
exhibit
small
plaqu
phenotyp
particularli
pronounc
ifncompet
cell
also
appar
lesser
extent
ifnlack
vero
cell
plaqu
size
assess
cell
due
overal
poor
multicycl
replic
ko
cell
line
cours
determin
replic
kinet
ko
observ
mutant
caus
syncytia
format
cpe
vero
cell
investig
phenomenon
cell
infect
high
moi
tcid
cell
cpe
inspect
microscopi
ko
caus
extens
syncytia
format
hpi
follow
cpe
destroy
infect
cell
monolay
hpi
fig
contrast
caus
signific
cpe
cell
line
syncytia
form
cell
day
pi
fig
data
shown
cpe
visibl
either
viru
cell
possibl
due
poor
replic
ko
cell
line
recent
mutant
express
ifn
antagonist
c
protein
shown
caus
extens
cpe
within
day
infect
vitro
contrast
noncytopath
wt
cpe
associ
extens
apoptosi
bartlett
et
al
sinc
v
protein
piv
report
inhibit
apoptosi
sun
et
al
wansley
park
sinc
cpe
induc
look
similar
observ
next
explor
whether
cpe
induc
ko
might
also
due
apoptosi
experi
use
virus
posit
neg
wt
control
apoptosi
determin
frequenc
apoptosi
infect
cell
use
flow
cytometri
detect
activ
major
effector
caspas
apoptot
pathway
replic
cultur
cell
infect
ko
control
virus
moi
tcid
cell
fix
hpi
cell
permeabil
immunostain
activ
describ
previous
potent
induc
activ
fig
specif
cultur
infect
less
cell
express
activ
hpi
similar
mockinfect
cultur
approxim
posit
activ
contrast
cultur
infect
posit
control
greater
cell
hpi
express
activ
indic
cell
undergo
apoptosi
caus
slightli
apoptosi
cell
express
activ
hpi
p
b
unexpectedli
ko
infect
cultur
small
increas
activ
cell
hpi
compar
increas
statist
signific
p
b
expect
substanti
larger
increas
given
extent
cell
destruct
evid
light
microscop
evalu
fig
extens
cell
destruct
also
evid
decreas
forward
scatter
paramet
event
measur
fac
analysi
koinfect
cultur
fig
indic
reduc
cell
size
accumul
cell
debri
result
suggest
major
cell
infect
ko
die
apoptot
pathway
antibodi
activ
potenti
bind
nonspecif
necrot
cell
lead
overestim
percent
apoptot
cell
confirm
cleavag
activ
immunoblot
analysi
infect
cell
lysat
fig
observ
flow
cytometr
detect
activ
cleav
activ
form
detect
immunoblot
h
infect
ko
cleav
also
detect
lesser
extent
cell
infect
though
correl
result
seen
flow
cytometri
next
evalu
cytotox
quantif
plasma
membran
damag
one
ubiquit
intracellular
enzym
rapidli
releas
cultur
medium
upon
damag
plasma
membran
lactat
dehydrogenas
ldh
therefor
measur
activ
ldh
releas
cultur
media
allow
rapid
quantif
cell
whose
plasma
membran
damag
cytotox
effect
increas
level
ldh
activ
cultur
media
proport
number
dead
damag
cell
cultur
measur
ldh
releas
cell
hpi
found
ko
induc
approxim
ldh
releas
hpi
surprisingli
fig
conclud
data
ko
exhibit
mark
increas
abil
induc
cellcel
fusion
cytopath
compar
howev
unlik
ko
appear
caus
cpe
primarili
syncytia
format
necrosi
rather
induct
apoptosi
although
process
activ
infect
ko
one
possibl
explan
earli
appear
day
syncytia
ko
infect
cell
f
hn
may
accumul
plasma
membran
rapidli
cell
enhanc
cellcel
fusion
quantifi
express
f
hn
plasma
membran
stain
live
adher
cell
cell
surfac
express
f
hn
estim
level
express
fac
analysi
chose
method
would
allow
us
compar
rel
amount
f
hn
glycoprotein
incorpor
infect
cell
membran
without
involuntarili
analyz
intracellular
f
hn
use
techniqu
signific
differ
mean
fluoresc
intens
mfi
detect
f
hpi
mfi
vs
ko
hpi
mfi
vs
ko
similarli
mfi
hn
protein
compar
cell
infect
either
two
virus
hpi
mfi
vs
ko
hpi
mfi
vs
ko
sinc
unabl
detect
differ
cell
surfac
glycoprotein
express
conclud
factor
addit
level
f
hn
express
like
play
major
role
syncytia
format
howev
data
interpret
offer
caveat
infect
ko
dynam
process
cell
form
syncytia
other
detach
die
ad
uncertainli
interpret
f
hn
express
data
schaapnutt
et
al
virolog
ko
exhibit
enhanc
product
v
protein
shown
directli
bind
cytosol
dsrna
sensor
inhibit
product
respons
viral
infect
andrejeva
et
al
child
et
al
although
import
inhibit
sens
paramyxoviru
infect
yet
well
defin
sought
determin
effect
delet
v
protein
abil
block
induct
infect
cell
infect
moi
tcid
cell
ko
concentr
cultur
supernat
determin
elisa
detect
activ
fig
low
level
detect
respons
infect
cell
pgml
hpi
pgml
hpi
contrast
cell
infect
ko
show
markedli
increas
product
hpi
similar
result
found
use
type
ifn
bioassay
base
inhibit
plaqu
format
vsvgfp
data
shown
unlik
ko
appear
unabl
inhibit
product
infect
cell
cell
mockinfect
infect
ko
moi
tcid
cell
lyse
hpi
cell
lysat
resolv
page
electrophoresi
nativ
condit
immunoblot
use
identifi
monomer
dimer
form
c
type
ifn
signal
infect
ko
vero
cell
sixwel
plate
mockinfect
infect
ko
moi
tcid
cell
h
cell
left
untreat
treat
iuml
cultur
per
treatment
per
viru
h
cell
infect
vsvgfp
incub
h
phosphorimag
use
visual
vsvgfp
foci
graph
repres
percent
inhibit
vsvgfp
foci
se
versu
untreat
cell
protein
degrad
vero
cell
infect
moi
tcid
cell
lyse
hpi
analyz
sdspage
immunoblot
gapdh
load
control
cellular
protein
p
v
viral
protein
ldh
cultur
supernat
activ
colorimetr
detect
reagent
detect
use
micropl
reader
activ
express
absorb
spontan
background
ldh
releas
determin
cultur
supernat
mockinfect
cell
maxim
releas
ldh
activ
determin
supernat
lyse
mockinfect
cultur
product
respons
viru
infect
initi
transcript
factor
activ
phosphoryl
caus
dimer
transloc
nucleu
bind
promot
yoneyama
et
al
evalu
dimer
respons
infect
cell
infect
ko
moi
tcid
cell
dimer
assay
perform
hpi
inhibit
dimer
wherea
ko
induc
dimer
fig
dimer
evid
mockinfect
cell
therefor
dimer
follow
ko
infect
correl
well
high
level
product
respons
viru
ko
block
ifn
signal
target
degrad
v
protein
effici
block
type
ifn
signal
follow
infect
target
proteasom
degrad
andrejeva
et
al
nishio
et
al
nishio
et
al
therefor
determin
effect
delet
v
protein
abil
block
type
ifn
signal
use
biolog
assay
assess
establish
antivir
state
cell
vero
cell
produc
type
ifn
mockinfect
infect
moi
tcid
cell
h
prior
treatment
twentyfour
hour
treatment
cell
infect
vesicular
stomat
viru
express
green
fluoresc
protein
vsvgfp
number
vsvgfp
plaqu
count
h
later
percent
inhibit
plaqu
format
due
treatment
calcul
rel
cell
treat
fig
cell
infect
mock
vsvgfp
replic
inhibit
treatment
iuml
averag
size
area
remain
plaqu
reduc
approxim
ifntreat
well
compar
size
plaqu
untreat
well
contrast
infect
reduc
inhibitori
effect
ie
level
indic
prevent
signal
therebi
blunt
induct
antivir
state
infect
ko
unabl
inhibit
antivir
effect
result
inhibit
vsvgfp
plaqu
format
cell
ident
mockinfect
cultur
plaqu
format
vsvgfp
cell
infect
ko
even
absenc
ifn
treatment
inhibit
data
shown
reason
undefin
like
involv
enhanc
cpe
observ
viru
thu
magnitud
ifnmedi
inhibit
associ
mutant
calcul
base
reduc
number
vsvgfp
plaqu
form
ko
infect
monolay
absenc
ad
investig
whether
ko
unabl
block
ifn
signal
lack
abil
degrad
examin
lysat
vero
cell
infect
moi
tcid
cell
express
protein
fig
hpi
complet
degrad
infect
cell
continu
prevent
accumul
hpi
ko
infect
cell
howev
express
level
high
higher
mockinfect
cell
hpi
although
degrad
ko
infect
cell
lysat
express
equival
amount
also
observ
could
still
phosphoryl
respons
stimul
cell
infect
either
ko
prior
lysi
perform
immunoblot
use
antibodi
specif
phosphoryl
form
data
shown
therefor
ko
appear
unabl
degrad
elimin
abil
block
type
ifn
signal
wherea
neither
ko
appear
affect
stabil
phosphoryl
assess
abil
ko
replic
vivo
inocul
african
green
monkey
agm
intranas
intratrach
tcid
viru
per
site
determin
viru
titer
nasopharyng
swab
repres
urt
tracheal
lavag
sampl
repres
lrt
fig
replic
mean
peak
titer
tcid
ml
urt
approxim
tcid
ml
lrt
howev
ko
undetect
agm
respiratori
tract
sampl
lower
limit
detect
log
tcid
ml
like
result
poor
replic
ko
also
poorli
immunogen
infect
caus
rise
neutral
antibodi
titer
agm
day
day
pi
signific
rise
respons
ko
poor
growth
lack
immunogen
ko
agm
indic
v
protein
requir
infect
vivo
suggest
vdelet
mutant
would
make
success
vaccin
candid
v
protein
implic
host
rang
restrict
paramyxoviru
replic
parisien
et
al
park
et
al
want
determin
replic
could
seen
primari
epitheli
cell
cultur
human
origin
vitro
model
human
airway
epithelium
hae
deriv
primari
human
airway
cell
grown
airliquid
interfac
differenti
multilay
polar
epithelium
unlik
transform
monolay
cell
line
primari
polar
epitheli
cultur
close
mimic
morpholog
physiolog
characterist
human
airway
epithelium
vivo
includ
mucu
product
ciliari
motion
pickl
et
al
hae
model
use
investig
characterist
infect
number
respiratori
virus
includ
human
coronavirus
influenza
viru
rsv
bartlett
et
al
leonard
et
al
sim
et
al
thompson
et
al
zhang
et
al
zhang
et
al
present
studi
found
follow
apic
inocul
hae
cell
moi
tcid
cell
replic
effici
reach
peak
titer
tcid
ml
fig
howev
agm
sampl
ko
undetect
hae
cultur
supernat
day
pi
appear
unabl
infect
hae
product
fig
determin
whether
high
level
ifn
product
limit
growth
ko
hae
cultur
measur
concentr
secret
elisa
fig
low
level
detect
respons
infect
hae
peak
pgml
day
pi
contrast
cell
infect
ko
show
littl
secret
b
pgml
like
due
viru
sever
restrict
replic
evalu
mutant
toshiba
strain
either
contain
delet
vspecif
cysteinerich
domain
design
encod
alter
p
edit
site
result
ablat
v
express
design
nishio
et
al
indic
v
requir
effici
replic
particularli
ifncompet
cell
sought
prepar
character
independ
v
ko
examin
effect
delet
synthesi
signal
ifn
cytopatholog
replic
vitro
vivo
end
ko
gener
use
low
passag
isol
replic
effici
agm
complet
sequenc
confirm
sequenc
compar
wt
viru
deriv
sinc
delet
ifn
antagonist
protein
influenza
viru
ferko
et
al
hai
et
al
talon
et
al
respiratori
syncyti
viru
teng
et
al
whitehead
et
al
wright
et
al
attenu
virus
vivo
potenti
use
live
attenu
viru
vaccin
particularli
interest
see
ko
properti
suitabl
vaccin
ko
impair
replic
vitro
indic
low
frequenc
recoveri
infecti
viru
cdna
consider
restrict
replic
vitro
particularli
ifncompet
cell
ko
replic
vero
cell
cell
line
unabl
produc
type
ifn
emeni
morgan
mosca
pitha
wathelet
et
al
also
low
constitut
express
chew
et
al
restrict
peak
titer
multicycl
replic
compar
wherea
previous
describ
restrict
cell
line
nishio
et
al
reason
differ
replic
two
construct
ko
defin
noteworthi
present
studi
entir
sequenc
ko
mutant
analyz
identifi
singl
adventiti
mutat
involv
substitut
n
geneend
signal
chang
length
poli
segment
residu
type
chang
common
paramyxovirus
usual
innocu
collin
crow
kolakofski
et
al
rassa
et
al
mutat
alter
length
untransl
region
variabl
geneend
poli
tract
demonstr
function
equival
direct
polyadenyl
rassa
et
al
viru
larg
replic
compet
reduc
express
n
p
protein
suggest
singl
adventiti
mutat
inconsequenti
ko
clean
vdelet
mutant
note
may
increas
express
p
protein
due
elimin
rna
edit
method
ablat
v
express
remov
possibl
gener
truncat
v
w
protein
introduc
possibl
greater
p
express
may
also
contribut
reduct
ko
replic
reduct
replic
reduc
plaqu
size
ko
versu
vero
cell
identifi
modest
ifnindepend
role
v
support
replic
vitro
role
v
replic
vitro
seen
rubulavirus
could
due
recent
report
function
v
promot
viru
growth
interact
l
polymeras
ctermin
truncat
mutant
v
protein
restrict
replic
ifncompet
cell
grew
effici
wt
vero
cell
delet
mutant
lack
entir
v
protein
could
recov
ifncompet
cell
howev
report
rubulaviru
v
knockout
truncat
mutant
grow
poorli
form
pinpoint
plaqu
sever
restrict
replic
seen
rubulaviru
v
knockout
v
truncat
mutant
ifncompet
cell
seen
similar
v
mutant
deriv
virus
paramyxoviru
genera
group
agm
inocul
intranas
intratrach
tcid
n
ko
n
mean
daili
viru
titer
se
nasopharyng
swab
repres
urt
tracheal
lavag
fluid
repres
lrt
determin
indic
sampl
day
limit
detect
log
tcid
ml
b
primari
polar
human
airway
epitheli
hae
tissu
cultur
close
model
authent
airway
epithelium
infect
apic
surfac
ko
low
moi
tcid
cell
viru
shed
apic
compart
determin
day
pi
viru
titer
shown
mean
duplic
cultur
two
donor
se
limit
detect
log
tcid
ml
c
induct
infect
hae
apic
wash
fluid
analyz
determin
elisa
level
determin
comparison
standard
curv
level
express
pgml
se
base
duplic
sampl
two
donor
lower
limit
detect
pgml
delenda
et
al
kato
et
al
patterson
et
al
respiroviru
sendai
viru
sev
exampl
grow
effici
ifncompet
cell
without
v
protein
suggest
v
less
crucial
replic
respirovirus
rubulavirus
delenda
et
al
kato
et
al
like
genera
also
possess
accessori
c
protein
found
rubulavirus
function
rubulaviru
v
protein
distribut
v
c
protein
genera
taken
togeth
data
point
toward
role
ifndepend
ifnindepend
function
v
enabl
viru
replic
vitro
ko
infect
cell
produc
effici
wherea
clearli
indic
v
protein
inhibit
induct
ifn
paramyxoviru
v
protein
examin
date
shown
downregul
induct
use
mechan
link
interact
cterminu
v
protein
helicas
domain
block
activ
signal
andrejeva
et
al
berghal
et
al
child
et
al
child
et
al
although
sever
studi
indic
rigi
primari
helicas
sens
paramyxovirus
rather
kato
et
al
loo
et
al
conserv
interact
across
four
abovement
paramyxoviru
genera
signifi
role
like
import
rigi
seem
target
paramyxoviru
v
protein
child
et
al
yoneyama
et
al
appar
function
effici
cell
infect
rubulavirus
produc
activ
induc
remain
undefin
also
inhibit
signal
effici
degrad
wherea
ko
confirm
previou
observ
modul
ifn
signal
human
monkey
cell
proteasom
degrad
rather
target
rubulavirus
muv
andrejeva
et
al
didcock
et
al
didcock
et
al
nishio
et
al
nishio
et
al
parisien
et
al
preciou
et
al
ulan
horvath
ulan
et
al
young
et
al
demonstr
degrad
block
antivir
effect
agmderiv
vero
cell
ko
support
use
agm
suitabl
vivo
model
examin
effect
v
replic
vivo
like
reflect
observ
human
monkey
protein
highli
conserv
share
amino
acid
ident
respect
speci
nishio
et
al
ko
infect
induc
extens
cpe
vitro
wherea
larg
noncytopath
late
infect
sever
divers
complex
pathway
lead
pivinduc
apoptosi
v
play
role
prevent
apoptosi
infect
cell
lei
et
al
peter
et
al
sun
et
al
wansley
park
sev
v
mutant
virus
like
ko
cytopath
respect
wt
virus
capraro
et
al
kato
et
al
v
truncat
mutant
induc
cell
death
vero
cell
present
studi
mechan
cell
death
ko
infect
cell
character
find
indic
cpe
appear
sole
apoptot
natur
observ
significantli
syncytia
format
upon
infect
ko
begin
earli
time
infect
sinc
ko
mutant
ident
protein
sequenc
except
v
delet
differ
syncytia
phenotyp
due
differ
sequenc
f
hn
although
chang
f
hn
clearli
alter
phenotyp
yuasa
et
al
ko
exhibit
greater
necrosi
cell
induc
low
level
apoptosi
relationship
syncytia
format
necrosi
defin
thu
apoptosi
cell
necrosi
syncytia
format
contribut
enhanc
cpe
seen
ko
infect
necrosi
appear
greater
contributor
apoptosi
ko
recov
urt
lrt
agm
indic
v
protein
requir
detect
replic
vivo
nonhuman
primat
address
whether
restrict
replic
specif
organ
epithelium
monkey
ie
host
rang
effect
could
specifi
v
protein
parisien
et
al
park
et
al
replic
ko
also
examin
human
organ
epitheli
cultur
replic
seen
human
organ
epitheli
cell
confirm
v
profound
effect
replic
human
monkey
organ
epithelia
abil
v
mutant
virus
exhibit
attenu
vivo
seen
paramyxovirus
v
mutant
restrict
replic
ferret
mice
clear
host
rang
differ
capraro
et
al
measl
viru
v
ko
mutant
attenu
rhesu
monkey
assess
absenc
clinic
ill
reduct
magnitud
durat
viremia
similarli
v
protein
defect
canin
distemp
viru
restrict
replic
ferret
von
messl
et
al
sev
v
mutant
replic
effici
vitro
significantli
attenu
mice
shorter
durat
replic
approxim
lower
peak
titer
wt
sev
kato
et
al
kato
et
al
greater
restrict
ko
vivo
morbilliviru
sev
v
mutant
perhap
due
v
role
sole
ifn
antagonist
wherea
measl
sev
v
c
protein
contribut
ifn
antagon
inabl
ko
replic
detect
titer
nonhuman
primat
hae
suggest
mutant
would
suitabl
candid
develop
live
attenu
vaccin
ie
overattenu
vivo
develop
live
attenu
vaccin
base
loss
v
protein
ifn
antagonist
function
would
requir
put
ifn
antagonist
domain
v
alter
select
domain
respons
protein
function
genom
replic
viral
fit
viru
assembl
defin
remain
unalt
vaccin
virus
current
construct
mutant
virus
v
p
gene
express
separ
gene
permit
introduct
mutat
v
without
affect
p
contribut
individu
function
v
attenu
immunogen
assess
appropri
util
vaccin
develop
clearli
loss
v
function
overattenu
vivo
human
atcc
ccl
rhesu
monkey
atcc
ccl
cell
maintain
optimem
invitrogen
grand
island
ny
supplement
fb
gentamicin
sulfat
african
green
monkey
vero
cell
atcc
maintain
mem
gibcoinvitrogen
supplement
fb
gentamicin
sulfat
mm
lglutamin
human
cell
atcc
maintain
nutrient
mixtur
gibcoinvitrogen
supplement
fb
gentamicin
sulfat
mm
lglutamin
hae
cell
isol
airway
specimen
patient
without
underli
lung
diseas
tissu
provid
nation
diseas
research
interchang
ndri
philadelphia
pa
unc
cystic
fibrosi
center
tissu
cultur
core
excess
tissu
follow
lung
transplant
accord
protocol
approv
univers
north
carolina
chapel
hill
institut
review
board
primari
cell
deriv
singl
patient
sourc
first
expand
plastic
plate
collagenco
permeabl
transwellcol
diamet
support
densiti
cell
per
well
hae
cultur
grown
custom
media
provis
airliquid
interfac
week
form
differenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epithelium
previous
describ
pickl
et
al
recombin
describ
base
biolog
deriv
strain
isol
nasal
wash
specimen
infect
infant
kindli
provid
dr
peter
wright
vanderbilt
univers
skiadopoulo
et
al
sequenc
strain
determin
previous
genbank
access
recombin
wildtyp
viru
previous
refer
deriv
antigenom
cdna
copi
genom
nolan
et
al
contain
phenotyp
silent
noti
restrict
site
introduc
upstream
nontransl
region
n
gene
nucleotid
posit
silent
c
substitut
posit
code
region
f
gene
describ
previous
nolan
et
al
skiadopoulo
et
al
recombin
vesicular
stomat
viru
express
green
fluoresc
protein
vsvgfp
kindli
suppli
john
hiscott
stojdl
et
al
propag
vero
cell
recombin
viru
express
p
protein
pv
gene
ko
creat
sitedirect
pcr
mutagenesi
use
advantagehf
pcr
kit
clontech
laboratori
palo
alto
ca
four
uniqu
silent
restrict
enzym
site
insert
antigenom
sens
cdna
facilit
incorpor
p
gene
contain
mutat
edit
site
asci
site
nucleotid
gccacaca
ggcgcgcc
bsteii
agei
site
nucleotid
ggtgcaatca
ggttaccggt
sacii
site
nucleotid
ccgatc
ccgcgg
viru
recov
revers
genet
plasmid
contain
new
restrict
enzym
site
grew
equival
cell
cultur
data
shown
pcr
mutagenesi
use
modifi
rna
edit
site
agggggggag
agaggaggtgag
chang
underlin
ad
two
g
residu
shift
read
frame
encod
p
ii
chang
three
seven
consecut
g
residu
prevent
edit
mutat
silent
p
orf
addit
four
nucleotid
tgac
insert
noncod
sequenc
bsteiiagei
site
correct
rule
six
skiadopoulo
et
al
region
mutat
cdna
subject
vitro
polymeras
reaction
sequenc
use
perkinelm
abi
sequenc
bigdy
sequenc
kit
perkinelm
appli
biosystem
warrington
uk
previous
describ
newman
et
al
ko
recov
revers
genet
cell
propag
cell
describ
previous
nolan
et
al
skiadopoulo
et
al
ko
biolog
clone
serial
termin
dilut
cell
confirm
recov
recombin
virus
contain
introduc
mutat
viral
rna
amplifi
rtpcr
use
superscript
firststrand
synthesi
system
invitrogen
advantagehf
pcr
kit
clontech
sequenc
determin
entireti
previous
describ
newman
et
al
skiadopoulo
et
al
control
rtpcr
reaction
rt
omit
yield
amplifi
product
confirm
sequenc
repres
viral
rna
purifi
viru
stock
obtain
infect
vero
cell
follow
centrifug
band
cultur
supernat
contain
viru
discontinu
wtvol
sucros
gradient
minim
contamin
cellular
factor
ifn
viru
titer
determin
serial
dilut
cell
plate
use
hemadsorpt
guinea
pig
erythrocyt
detect
infect
cultur
hall
et
al
skiadopoulo
et
al
titer
express
log
tcid
ml
tissu
cultur
infecti
doseml
whole
cell
lysat
prepar
lyse
cell
uninfect
hpi
radioimmunoprecipit
assay
ripa
buffer
contain
mm
tri
ph
mm
nacl
igep
sigmaaldrich
st
loui
mo
sodium
dodecyl
sulfat
sd
open
biosystem
huntsvil
al
deoxychol
acid
sigmaaldrich
mm
naf
mm
na
vo
complet
mini
proteas
inhibitor
tablet
roch
indianapoli
lysat
heat
minut
nupag
ld
sampleload
buffer
invitrogen
separ
sdspolyacrylamid
gel
electrophoresi
sdspage
nupag
bistri
gel
denatur
reduc
condit
invitrogen
nativepag
analysi
monom
dimmer
cell
lyse
buffer
contain
mm
trishcl
ph
mm
nacl
igep
sigmaaldrich
mm
naf
mm
na
vo
complet
mini
proteas
inhibitor
tablet
roch
nativepag
perform
use
polyacrylamid
gel
trisglycin
run
buffer
biorad
hercul
ca
contain
sodium
deoxychol
cathod
chamber
van
cleve
et
al
gel
first
prerun
min
prior
electrophoresi
lysat
immunoblot
protein
transfer
invitrolon
pvdf
membran
invitrogen
block
phosphatebuff
salin
pb
contain
tween
milk
powder
incub
primari
antibodi
indic
primari
antibodi
use
immunoblot
mous
antigapdhperoxidas
sigmaaldrich
rabbit
santa
cruz
biotechnolog
santa
cruz
ca
rabbit
santa
cruz
biotechnolog
rabbit
santa
cruz
biotechnolog
rabbit
antiphospho
chemiconmillipor
billerica
rabbit
cell
signal
technolog
danver
mous
antibodi
aminotermin
pv
common
region
tsurudom
et
al
ctermin
v
uniqu
region
nishio
et
al
describ
previous
rabbit
polyclon
antiserum
rais
synthet
peptid
n
protein
amino
acid
cheqyrgsqdddandatd
gener
spring
valley
laboratori
inc
woodbin
md
protein
detect
incub
membran
horseradish
peroxidaseconjug
goat
antirabbit
goat
antimous
igg
kpl
gaithersburg
md
visual
use
supersign
west
pico
chemiluminesc
substrat
pierc
rockford
il
confluent
monolay
cultur
vero
cell
plate
infect
triplic
multipl
infect
moi
either
tcid
cell
indic
incub
h
viru
cultur
wash
three
time
incub
medium
well
harvest
replac
fresh
medium
h
interv
viru
present
sampl
quantifi
titrat
cell
detect
hemadsorpt
level
temperatur
sensit
replic
determin
compar
level
ko
replic
permiss
temperatur
elev
temperatur
previous
describ
nolan
et
al
skiadopoulo
et
al
evalu
plaqu
size
perform
vero
cell
monolay
incub
infect
cultur
cover
methylcellulos
overlay
ten
day
pi
infect
cultur
fix
methanol
viral
plaqu
immunostain
use
rabbit
antiserum
rais
purifi
viru
spring
valley
laboratori
inc
goat
antirabbit
secondari
antibodi
conjug
horseradish
peroxidas
kpl
plaqu
visual
use
peroxidas
substrat
kpl
plaqu
size
measur
use
adob
photoshop
softwar
mean
plaqu
size
pixel
standard
error
se
base
plaqu
per
viru
detect
activ
cell
harvest
scrape
h
infect
moi
tcid
cell
cell
wash
pb
fix
permeabil
bd
cytofixcytoperm
solut
bd
bioscienc
san
diego
ca
wash
bd
permwash
buffer
cell
stain
fluorescein
isothiocyan
fitc
conjug
monoclon
rabbit
antiact
antibodi
accord
manufactur
protocol
fitc
activ
apoptosi
kit
bd
bioscienc
detect
cell
surfac
express
hn
f
protein
cell
harvest
trypsin
h
infect
moi
tcid
cell
cell
wash
pb
stain
antibodi
dilut
fac
buffer
pb
fb
mous
antihn
mous
antif
tsurudom
et
al
follow
secondari
antibodi
antimous
antimous
alexafluor
invitrogen
molecular
probe
stain
cell
fix
fac
buffer
plu
paraformaldehyd
prior
analysi
sampl
analysi
perform
facscalibur
bd
bioscienc
use
cellquestpro
softwar
analysi
perform
use
flowjo
softwar
treestar
inc
ashland
cellular
toxic
due
hpiv
infect
determin
measur
amount
lactat
dehydrogenas
ldh
leakag
cell
cultur
media
media
collect
hpivinfect
cell
cultur
centrifug
immedi
collect
elimin
cell
cell
debri
ldh
releas
quantifi
supernat
use
cytotox
detect
kit
plu
ldh
roch
accord
manufactur
direct
maximum
ldh
releas
cell
lysi
control
determin
ad
lysi
reagent
roch
mockinfect
cultur
prior
supernat
collect
centrifug
background
ldh
releas
determin
mockinfect
cultur
lyse
ldh
activ
upon
reaction
colorimetr
reagent
measur
use
micropl
reader
vmax
molecular
devic
sunnyval
ca
cultur
supernat
cell
apic
wash
fluid
hae
cultur
analyz
level
use
human
elisa
kit
accord
manufactur
protocol
fujirebio
inc
tokyo
japan
elisa
kit
specif
recogn
biolog
activ
form
human
absorb
measur
use
micropl
reader
vmax
molecular
devic
compar
known
concentr
standard
ifn
concentr
express
mean
pgml
se
elisa
result
verifi
use
type
ifn
bioassay
base
inhibit
vsvgfp
replic
previous
describ
bartlett
et
al
park
et
al
vero
cell
mockor
moi
tcid
cell
h
cell
left
untreat
treat
iuml
avonex
biogen
inc
cambridg
h
prior
infect
vsvgfp
vsvgfpinfect
cell
cultur
methylcellulos
overlay
prepar
mem
supplement
gentamicin
sulfat
mm
lglutamin
plate
read
gfp
express
h
vsvgfp
infect
use
typhoon
scanner
molecular
dynam
number
vsvgfpposit
foci
count
van
cleve
et
al
african
green
monkey
agm
inocul
intranas
intratrach
ml
media
contain
tcid
per
site
nasopharyng
np
swab
collect
day
pi
tracheal
lavag
tl
sampl
collect
day
pi
viru
titer
determin
serial
dilut
sampl
cell
describ
express
log
tcid
ml
lower
limit
detect
log
tcid
ml
antibodi
respons
determin
plaqu
reduct
neutral
titer
prnt
assay
cell
monolay
serum
sampl
collect
agm
studi
day
pi
test
sera
heat
inactiv
min
serial
dilut
begin
made
optimem
supplement
fb
dilut
tcid
ml
ad
dilut
serum
incub
h
viru
serum
mixtur
ad
cell
monolay
plate
rock
h
overlaid
methylcellulos
optimem
incub
day
cell
fix
methanol
aceton
immunostain
use
rabbit
antiserum
goat
antirabbit
secondari
antibodi
conjug
horseradish
peroxidas
kpl
plaqu
visual
use
trueblu
peroxidas
substrat
kpl
prior
inocul
apic
surfac
hae
rins
pb
remov
apic
surfac
secret
fresh
medium
suppli
basolater
compart
hae
cultur
inocul
low
moi
tcid
cell
inocula
appli
apic
surfac
cultur
incub
h
apic
surfac
cultur
rins
min
pb
return
incub
apic
wash
sampl
collect
day
pi
incub
apic
surfac
media
min
apic
wash
media
recov
store
viru
titer
determin
describ
